Scientific advisers to the C.D.C. have been discussing the details of federal guidance on who qualifies for a Pfizer-BioNTech booster shot and why. A decision is expected on Thursday.

from NYT > Health https://ift.tt/2ZfcCvq

0 comments:

Post a Comment

Popular Posts